Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Estimation of the Incidence of Methemoglobinemia Associated With Ferric Carboxymaltose Administration

NCT06958822 is registered in ClinicalTrials.gov with Ordu University as lead sponsor.

NCT NCT06958822
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06958822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Estimation of the Incidence of Methemoglobinemia Associated With Ferric Carboxymaltose Administration
Lead sponsor
Ordu University
Phase
Observational
Overall status
Completed
Start date
April 14, 2025
Completion date
September 30, 2025
Enrollment
977 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, iron-deficiency, ferric carboxymaltose, methemoglobinemia, parenteral iron therapy